Praxis Precision Medicines Inc. (PRAX) PT Raised to $945 at Raymond James

August 17, 2026 6:15 AM

Raymond James analyst Tiago Fauth raised the price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX) to $945.00 (from $765.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found